• Find people
• Intranet

News / General information

• 16/11/2010 - General information

  Important progress made on the human immune system’s ability to tackle cytomegalovirus

  

  A study directed by Miguel López-Botet, director of the IMIM (Hospital del Mar Research Institute) and coordinator of the Immunology Laboratory of the Health and Experimental Science Department (CEXS), has identified the receptors involved in triggering the cytotoxic activity of human NK (natural killer) cells in response to human cytomegalovirus (HCMV)-infected dendritic cells.

  Més informació "Important progress made on the human immune system’s ability to tackle cytomegalovirus"

• 12/07/2010 - General information

  20th European Athletics Championships

  The City of Barcelona will host from 27 July to 1 August 2010 the 20th European Athletics Championships, Barcelona 2010. The Hospital del Mar will be one of the reference hospitals for both its timetabled care (tests) as well as emergency services and the IMIM's Anti-Doping Control Laboratory will be in charge of performing the doping control tests for the championships

  Més informació "20th European Athletics Championships"

• 07/07/2010 - General information

  Kidney disease in patients with heart-related chest pain increases the mortality risk

  According to an international study which IMIM took part, kidney disease is a significant predictor of in-hospital mortality and 30-day mortality in patients who come to the hospital with heart-related chest pain, otherwise known as Non-ST-segment Elevation Acute Coronary Syndrome (NSTE-ACS).

  Més informació "Kidney disease in patients with heart-related chest pain increases the mortality risk"

• 28/05/2010 - General information

  Commercial release of Pentacle, an advanced tool for 3D QSAR and Virtual screening developed at GRIB

  Molecular Discovery Ltd, one of the world leader companies in chemoinformatics and services for the pharmaceutical industry has launched to the market the software Pentacle, developed at the Computer of Assisted Drug Design (CADD) laboratory by Ángel Durán and Manuel Pastor.

  Més informació "Commercial release of Pentacle, an advanced tool for 3D QSAR and Virtual screening developed at GRIB"

• 15/04/2010 - General information

  A work published in Genome Research identifies many new functional amino acid tandem repeats in human proteins

  

  The Evolutionary Genomics group of GRIB (IMIM- UPF), led by Mar Albà, has published at the journal Genome Research a study that shows, using a comparative genomics approach, that many more amino acid tandem repeats in human proteins than previously suspected are likely to be functional.

  Més informació "A work published in Genome Research identifies many new functional amino acid tandem repeats in human proteins"

• 01/03/2010 - General information

  iPHACE, Software to Visually Explore Pharmacological Space

  

  On 15 February, the international journal Bioinformatics, one of the best in the field of mathematics and computational biology, published an article on a web application developed by the Laboratorio de Quimiogenómica, directed by Jordi Mestres, which is part of the IMIM-UPF Biomedicine IT Research Group (GRIB).

  Més informació "iPHACE, Software to Visually Explore Pharmacological Space"

• 25/02/2010 - General information

  José Antonio Pascual re-elected as President of the IPC Anti-doping Committee

  

  José Antonio Pascual, member of the Bioanalysis and Analytical Services Research Group of the Neuropsychopharmacology Programme and deputy director of the Anti-doping Control Laboratory, has been re-elected President of the International Paralympic Committee’s Anti-doping Committee for the next 4 years.

  Més informació "José Antonio Pascual re-elected as President of the IPC Anti-doping Committee"

• 23/02/2010 - General information

  25 European organisations unite their efforts towards a better prediction of toxic effects of new drug candidates

  

  The Innovative Medicines Initiative (IMI) funds for 5 years a consortium consisting of 13 European pharmaceutical companies and 12 academic groups and SMEs to develop information technologies-based solutions for improved toxicity prediction of new drug candidates. The academic coordination of the project is in charge of Ferran Sanz, Director of GRIB (IMIM-UPF).

  Més informació "25 European organisations unite their efforts towards a better prediction of toxic effects of new drug candidates"

• 28/01/2010 - General information

  IntOgen, an interface designed as an essential tool for cancer research

  

  IntOgen, an interface designed as an essential tool for cancer research The Biomedical Genomics laboratory of the IMIM and UPF’s Biomedical Informatics Research Group (GRIB in Spanish), led by Núria Lopez-Bigas, has developed an innovative system for analysing and integrating large amounts of cancer genomic data.The results produced by this multidimensional resource, known as IntOGen, can be viewed on the web interface www.intogen.org.

  Més informació "IntOgen, an interface designed as an essential tool for cancer research"

• 25/01/2010 - General information

  An IMIM study makes the American Heart Association’s top 10 list

  

  Every year since 1996, the American Heart Association lists the top 10 most important scientific advances related to cardiovascular diseases and stroke. This year, the top 10 includes a study involving researchers from the Cardiovascular Epidemiology and Genetics Research Group from IMIM-Hospital del Mar. It was published last June in the prestigious journal Nature Genetics.

  Més informació "An IMIM study makes the American Heart Association’s top 10 list"